GC Labs, GC Cell and GC Genome Jointly Participate in Laboratory Medicine Conference

[Financial News] GC Labs introduced its capabilities in precision medicine collaboration, linking diagnostic testing, genomic analysis and biologistics with GC Cell and GC Genome.
GC Labs said on the 29th that it had jointly participated with its two affiliates in 'LMCE 2026 and the 67th International Congress of the Korean Society for Laboratory Medicine,' held at Grand Walkerhill Seoul from the 21st to the 23rd.
The conference, organized by the Korean Society of Laboratory Medicine, was held under the theme 'AI for AI (Advanced Integration).' Laboratory medicine experts from Korea and abroad discussed ways to incorporate artificial intelligence (AI) and data technologies into diagnostic testing. This year, marking the 10th anniversary of LMCE, the conference also highlighted advances in related technologies and the future healthcare environment.
As part of the academic program, Ko Un-young, director of GC Labs' Center for International Health and Infectious Disease Research Collaboration, presented on 'Trends in Respiratory Virus Outbreaks in Korea: RSV and Influenza Surveillance.' Ko introduced seasonal and age-specific patterns of respiratory virus outbreaks in Korea and presented 'Epi-wave,' an infectious disease surveillance system that uses test data.
Epi-wave is a data dashboard developed based on GC Labs' polymerase chain reaction (PCR) test results from the past three years. It was designed to visualize weekly positivity rates and epidemic curves for 12 respiratory infectious diseases, as well as influenza trends by type and age group and regional positivity rates, to help users understand infectious disease outbreak patterns. The system was developed with support from the cross-ministerial R&D project for the development of infectious disease prevention and control technologies.
Through this joint participation, the three companies outlined a group-level direction for collaboration linking diagnostic testing, genomic analysis and biologistics, drawing on each company's expertise. They also shared examples of data-driven infectious disease surveillance and introduced the potential for using test data in precision medicine.
Lee Sang-gon, president of GC Labs, said, "Through collaboration among group companies, we will improve the quality and accuracy of diagnostic testing services and contribute to the advancement of precision medicine."

[email protected] Jeong Sang-hee Reporter